Zaloguj się

Gotowe bibliografie tematyczne / Hepatitis C

Spis treści

Artykuły w czasopismach
Rozprawy doktorskie
Książki
Części książek
Streszczenia konferencji
Raporty organizacyjne

Gotowa bibliografia na temat „Hepatitis C”

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 25 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Hepatitis C”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Hepatitis C"

1

Nouman, Muhammad Khuram, Bushra Zaidi, Ghulam Mohiuddin, Faryal Asif, and Muhammad Khan Malik. "HEPATITIS C." Professional Medical Journal 25, no. 03 (2018): 387–91. http://dx.doi.org/10.29309/tpmj/2018.25.03.381.

Pełny tekst źródła

Streszczenie:

Background: Hepatitis C virus (HCV) is the most communal source of non-A,non-B viral hepatitis in the world. The disease is illusory, and the majority of patients do notacquire jaundice at its onset. Treatment of hepatitis C with interferon attained a sustainedvirological response (SVR) in almost 50% of the patients with HCV infection. Viral genotype isimportant to determine the response. The present study aims to provide the incidence of relapseof HCV in patients taking interferon therapy and to identify the predictors for relapse. StudyDesign: Retrospective observational study. Setting: Depa

Style APA, Harvard, Vancouver, ISO itp.

2

Jamali, Ghulam Mustafa, Anwar Ali Jamali, and Habibullah Shaikh. "HEPATITIS C VIRUS;." Professional Medical Journal 24, no. 11 (2017): 1621–29. http://dx.doi.org/10.29309/tpmj/2017.24.11.646.

Pełny tekst źródła

Streszczenie:

Objectives: The plan of this current research was in the direction for towards theassessment of the existing ELISA (Enzyme Linked Immunosorbant Assay) method throughantibodies testing for identification of hepatitis C virus disease by comparing their outcome withthe Real Time polymerase chain reaction analysis. Setting: Peoples Medical College HospitalNawabshah. Period: December 2015 to December 2016. Methods: In this current research 100blood samples were analyzed due to the presence of anti-HCV antibodies by 3rd-generationenzyme-linked immunosorbent assay testing. All the specimens were 100%

Style APA, Harvard, Vancouver, ISO itp.

3

Jain, Ravi, and Ashok Yadav. "Hepatitis B Versus Hepatitis C in Blood Donors." Annals of Applied Bio-Sciences 4, no. 1 (2017): A8—A13. http://dx.doi.org/10.21276/aabs.2017.1306.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

TARIQ, FAQIR MUHAMMAD, IRSHAD AHMAD, HABIB SUBHANI, and Irshad Ul Haq. "HEPATITIS C." Professional Medical Journal 16, no. 02 (2009): 169–72. http://dx.doi.org/10.29309/tpmj/2009.16.02.2890.

Pełny tekst źródła

Streszczenie:

I n t r o d u c t i o n : Hepatitis C is a RNA virus isolated in 1988 but still not cultured in the laboratory. Hepatitis-C infection is aserious global public health issue, WHO estimates worlds 3 % population is HCV positive. Pakistan is also facing the huge burden of thisdisease. Accurate prevalence information for hepatitis C infection is scant in Pakistan. Few population based studies are available, the mostcomprehensive being that of Luby et al which after testing a representative sample from a population of 150,000 in Hafizabad, Pakistanfound an overall sero-prevalence of 6%. This increa

Style APA, Harvard, Vancouver, ISO itp.

5

Billah, Mustansar, Syed Muhammad Raza Shah, and Muhammad Mujtaba Hashir. "HEPATITIS B AND HEPATITIS C." Professional Medical Journal 25, no. 08 (2018): 1245–51. http://dx.doi.org/10.29309/tpmj/18.4766.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar, and Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV." Professional Medical Journal 21, no. 04 (2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Pełny tekst źródła

Streszczenie:

Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was

Style APA, Harvard, Vancouver, ISO itp.

7

Huma Qureshi, Saeed Akhter, Hassan Mahmood, et al. "Overview of Hepatitis C Elimination Efforts in Pakistan and the Launch of Prime Minister’s Programme for the Elimination of Hepatitis C." Journal of the Pakistan Medical Association 74, no. 12 (2024): 2188–90. http://dx.doi.org/10.47391/jpma.24-97.

Pełny tekst źródła

Streszczenie:

Hepatitis B and C are serious viral infections that cancause liver damage and death. According to the WorldHealth Organization (WHO), there are currently 2.8 millionpeople living with hepatitis B in Pakistan, and 9.8 millionpeople living with hepatitis C.1 These numbers representa significant burden of disease for the country. Thecurrent prevalence of hepatitis B in Pakistan is 1.1%,which corresponds to one-quarter of the burden of thedisease in the Eastern Mediterranean region.1 Theprevalence of hepatitis C is 7.5%, which is the highest inthe world. Almost 37,000 people die each year in Pakis

Style APA, Harvard, Vancouver, ISO itp.

8

Viana, Daniel Rodrigues, Nathalia Mundoco Veloso, Osvaldo Carvalho Neto, Nicolas Garcia Papacosta, Gabriel Martins Nunes, and Virgílio Ribeiro Guedes. "Hepatite B e C: diagnóstico e tratamento." Revista de Patologia do Tocantins 4, no. 3 (2017): 73. http://dx.doi.org/10.20873/uft.2446-6492.2017v4n3p73.

Pełny tekst źródła

Streszczenie:

INTRODUÇÃO: As hepatites virais são consideradas as principais doenças hepáticas, podendo levar a quadros mais graves, como a cirrose e o carcinoma hepatocelular, tornando-se um importante problema de saúde pública. Tem distribuição global com áreas de altos índices de endemicidade, sobretudo em países asiáticos. Os principais agentes envolvidos são os vírus da hepatite A, B, C, D, E. O vírus da hepatite B e C se destacam nesse meio devido à grande capacidade de cronificação. As formas de transmissão são basicamente através do contato com fluidos corporais infectados, através de transfusões sa

Style APA, Harvard, Vancouver, ISO itp.

9

Vijendra, Singh Rawat, Ranjan Neelima, Jain Isha, and Bharat Jain Savita. "Hepatitis B and Hepatitis C - Seroprevalence and Correlation with C-Reactive Protein." International Journal of Pharmaceutical and Clinical Research 15, no. 6 (2023): 2003–8. https://doi.org/10.5281/zenodo.12529982.

Pełny tekst źródła

Streszczenie:

<strong>Background: </strong>Viral hepatitis caused by Hepatitis B(HBV) and Hepatitis C virus (HCV) is a major public health problem specially in developing countries like India. <strong>Materials and Methods: </strong>Three hundred blood samples were collected from patients having clinical sign and symptoms of hepatitis and apparently healthy pregnant females. Detection of hepatitis B surface antigen, antibodies against hepatitis C virus and C reactive protein (CRP) was done in these samples. <strong>Results:</strong> The seroprevalence of HBV and HCV in our study sam

Style APA, Harvard, Vancouver, ISO itp.

10

Andrade, Luís Jesuino, Paulo Melo, Isabel Lins, Raymundo Paraná, and Augusto Lins. "HEPATITIS C VIRUS AND HEPATITIS C-INFECTION." Brazilian Journal of Medicine and Human Health 3, no. 1 (2015): 19–28. http://dx.doi.org/10.17267/2317-3386bjmhh.v3i1.453.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Rozprawy doktorskie na temat "Hepatitis C"

1

Pajenčkovskytė, Karolina. "Sergančiųjų lėtiniu virusiniu C hepatitu genotipai." Master's thesis, Lithuanian Academic Libraries Network (LABT), 2004. http://vddb.library.lt/obj/LT-eLABa-0001:E.02~2004~D_20040608_165139-44050.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Berg, Thomas. "Chronische Hepatitis C." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2002. http://dx.doi.org/10.18452/13812.

Pełny tekst źródła

Streszczenie:

Die vorliegende Habilitationsschrift befasst sich schwerpunktmäßig vor allem mit der Klinik und Therapie der Hepatitis C. Evaluiert wurden: 1. verschiedene therapeutische Strategien, 2. die Ursachen der "Non-Response" auf eine anti-virale Therapie sowie 3. die klinische Relevanz der neu entdeckten Hepatitis-assoziierten Viren und 4. ihre Bedeutung bei Patienten mit akuter bzw. chronischer Lebererkrankung unklarer Ätiologie sowie bei Patienten vor und nach Lebertransplantation. Ad 1. Aus dem Vergleich verschiedener Therapie-Konzepte wie der Kurzzeit- Kombinationstherapie, Triple-Therapie

Style APA, Harvard, Vancouver, ISO itp.

3

Silva, Filho Hermes Pedreira da. "Estudo Molecular dos Vírus B e C das Hepatites nas Regiões Norte e Nordeste do Brasil." reponame:Repositório Institucional da FIOCRUZ, 2010. https://www.arca.fiocruz.br/handle/icict/4219.

Pełny tekst źródła

Streszczenie:

Submitted by Ana Maria Fiscina Sampaio (fiscina@bahia.fiocruz.br) on 2012-07-19T21:21:54Z No. of bitstreams: 1 Hermes Pedreira EStudo molecular dos vírus B e C...2010.pdf: 5589974 bytes, checksum: b86706272dbb22d0d349edae7d641ce1 (MD5)<br>Made available in DSpace on 2012-07-19T21:21:54Z (GMT). No. of bitstreams: 1 Hermes Pedreira EStudo molecular dos vírus B e C...2010.pdf: 5589974 bytes, checksum: b86706272dbb22d0d349edae7d641ce1 (MD5) Previous issue date: 2010<br>Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, Bahia, Brasil<br>Infecções pelos vírus B e C das hepatit

Style APA, Harvard, Vancouver, ISO itp.

4

Valente, Vanderleia Barbaro. "Estudo da distribuição dos marcadores sorológicos das hepatites B e C entre doadores de sangue do Hemocentro de Ribeirão Preto, SP." Universidade de São Paulo, 2002. http://www.teses.usp.br/teses/disponiveis/17/17139/tde-29052003-193717/.

Pełny tekst źródła

Streszczenie:

Este estudo, que envolveu todos os doadores de sangue (25.891) que compareceram pela primeira vez ao Hemocentro de Ribeirão Preto, de junho de 1996 a junho de 2001, teve os seguintes objetivos: 1) Estudar a positividade de marcadores sorológicos das hepatites B e C em testes da triagem dos doadores. 2) Analisar o fluxo dos doadores positivos para os marcadores das hepatites B e C ao Ambulatório de Hepatites (AH) do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto. 3) Estimar a prevalência de infecção atual ou pregressa pelos vírus das hepatites B e C entre os doadores, através

Style APA, Harvard, Vancouver, ISO itp.

5

Silva, Edvaldo Ferreira da. "Prevalência de marcadores sorológicos das hepatites A e B em pacientes com hepatite C crônica atendidos no ambulatório de hepatites do serviço de Gastroenterologia Clínica do Hospital das Clínicas da Faculdade de Medicina da Universidade." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/5/5168/tde-04022015-153903/.

Pełny tekst źródła

Streszczenie:

Introdução: Pacientes com infecção crônica pelo VHC e superinfecção pelo vírus da hepatite A (VHA) ou o vírus da hepatite B (VHB), têm maior morbi-mortalidade quando comparados com pacientes que apresentam infecção aguda somente pelo VHA ou VHB. A mortalidade associada à hepatite A aguda pode estar particularmente elevada em pacientes com pré-existência de hepatite crônica causada pelo VHC. Por esta razão, a imunização ativa com vacinas contra o VHA e o VHB vem a ser obrigatória nesta população, e consequentemente esta sorologia deve ser determinada. Objetivos: O objetivo deste trabalho foi a

Style APA, Harvard, Vancouver, ISO itp.

6

Thiel, Jens. "Einfluss von Immunsuppression auf Hepatitis-C-assoziierte Immunphänomene und Hepatitis-C-Quasispezies." [S.l.] : [s.n.], 2003. http://deposit.ddb.de/cgi-bin/dokserv?idn=969417918.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Shen, Hong. "Hepatitis C infection models." Thesis, Paris 5, 2012. http://www.theses.fr/2012PA05T016.

Pełny tekst źródła

Streszczenie:

L'hépatite C (VHC) est l'une des causes principales de maladies du foie dans le monde, qui représentent un risque élevé d'évoluer vers la cirrhose et le carcinome hépatocellulaire. Actuellement, le traitement standard de l’infection par le VHC est l'interféron pégylé-(peg-IFN) et la ribavirine. Bien que le taux de la réponse virale soutenue (RVS) au traitement se soit améliorée au cours de ces années, cette thérapie n'est pas efficace chez tous les patients. En outre, plusieurs effets secondaires toxiques, de complications et le coût élevé limitent la compliance du patient et l'efficacité du t

Style APA, Harvard, Vancouver, ISO itp.

8

Hopwood, Maxwell Norman. "Living with Hepatitis C." Maastricht : Maastricht : Universiteit Maastricht ; University Library, Universiteit Maastricht [host], 2007. http://arno.unimaas.nl/show.cgi?fid=9171.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Montes, Teves Pedro. "Hepatitis C: retos pendientes." Sociedad de Gastroenterología del Perú, 2014. http://hdl.handle.net/10757/331937.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Winckler, Fernanda Cristina. "Influência da Resposta inflamatória na resposta virológica sustentada em pacientes com hepatite C crônica genótipo 1 durante o tratamento antiviral com terapia tripla." Botucatu, 2016. http://hdl.handle.net/11449/144991.

Pełny tekst źródła

Streszczenie:

Orientador: Giovanni Faria Silva<br>Coorientador: Marjorie de Assis Golim<br>Resumo: A hepatite C é uma doença infecciosa que torna-se crônica em cerca de 85% dos infectadosque poderão desenvolver cirrose e carcinoma hepato celular. O tratamento antiviral em muitosdos pacientes não é eficaz, principalmente quando estes portam o genótipo 1 e fibroseavançada, a resposta inflamatória também desempenha seu papel sobre a resposta virológicasustentada (RVS) durante o tratamento com Interferon Peguilado (PegIFN) associado aRibavirina (RBV). Nesse estudo nosso objetivo principal foi avaliar a influênc

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Książki na temat "Hepatitis C"

1

Askari, Fred K. Hepatitis C, the silent epidemic: The authoritative guide. Perseus, 2001.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Askari, Fred K. Hepatitis C, the silent epidemic: The authoritative guide. Plenum Trade, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Sawyer, Forrest. Hepatitis C. Films for the Humanities & Sciences, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

England, Health Promotion, ed. Hepatitis C. Health Promotion England, 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

R, Foster G., ed. Hepatitis C. Baillière Tindall, 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

National Institute on Drug Abuse, ed. Hepatitis C. National Institute on Drug Abuse, U.S. Dept. of Health and Human Services, National Institutes of Health, 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Canada. Library of Parliament. Parliamentary Research Branch. Hepatitis C. Library of Parliament, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Ozaras, Resat, and Dominique Salmon-Ceron, eds. Viral Hepatitis: Chronic Hepatitis C. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-03757-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

N, Lau Johnson Y., ed. Hepatitis C protocols. Humana Press, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

W, Reesink H., ed. Hepatitis C virus. 2nd ed. Karger, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Części książek na temat "Hepatitis C"

1

Arends, Joop E., Maria Cristina Leoni, and Dominique Salmon. "Acute Hepatitis C." In Viral Hepatitis: Acute Hepatitis. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-03535-8_4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Arends, Joop E., Maria Cristina Leoni, and Dominique Salmon-Ceron. "Acute Hepatitis C." In Viral Hepatitis: Chronic Hepatitis C. Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-03757-4_11.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Korn, Klaus. "Hepatitis C." In S2k-Leitlinie - Labordiagnostik schwangerschaftsrelevanter Virusinfektionen. Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43481-9_13.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Dusheiko, Geoffrey. "Hepatitis C." In Sherlock's Diseases of the Liver and Biliary System. John Wiley & Sons, Ltd, 2018. http://dx.doi.org/10.1002/9781119237662.ch23.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Fried, Michael W., Jama M. Darling, and Stanley M. Lemon. "Hepatitis C." In Schiff's Diseases of the Liver. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119251316.ch25.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Kanto, Tatsuya, and Sachiyo Yoshio. "Hepatitis C." In Liver Immunology. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-51709-0_17.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Dusheiko, Geoffrey. "Hepatitis C." In Sherlock's Diseases of the Liver and Biliary System. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444341294.ch20.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Charlton, Michael, and Travis Dick. "Hepatitis C." In Practical Gastroenterology and Hepatology Board Review Toolkit. John Wiley & Sons, Ltd, 2016. http://dx.doi.org/10.1002/9781119127437.ch77.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Sainburg, Robert L., Andrew L. Clark, George E. Billman, et al. "Hepatitis C." In Encyclopedia of Exercise Medicine in Health and Disease. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_2485.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Darling, Jama M., Stanley M. Lemon, and Michael W. Fried. "Hepatitis C." In Schiff's Diseases of the Liver. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781119950509.ch25.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Hepatitis C"

1

Rabbi, Md Anayt, Tania Alam Suchi, Md Manowarul Islam, Arnisha Akhter, and Md Ashraf Uddin. "An Effective Machine Learning Framework for Hepatitis C Virus Prediction." In 2024 IEEE International Conference on Biomedical Engineering, Computer and Information Technology for Health (BECITHCON). IEEE, 2024. https://doi.org/10.1109/becithcon64160.2024.10962606.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Fatima, Arooj, and Jarutas Andritsch. "Machine Learning Model for Predicting Hepatocellular Carcinoma in Hepatitis C Patients." In 2024 2nd International Conference on Computing and Data Analytics (ICCDA). IEEE, 2024. https://doi.org/10.1109/iccda64887.2024.10867403.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Ekmen, Onder. "A Case of Fulminant Hepatitis B Reactivation After Hepatitis C Treatment in Hepatitis B+C Co-infection." In 39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0042-1760078.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Prasetia Nurwidda, Arvi Dian, Poernomo Boedi Setiawan, Iswan Abbas Nusi, et al. "Thrombocytopenia in Chronic Hepatitis C." In Surabaya International Physiology Seminar. SCITEPRESS - Science and Technology Publications, 2017. http://dx.doi.org/10.5220/0007340404460452.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

López, Sandra, Itxaso Respaldiza, and Ander Portugal. "Hepatitis C, el enemigo silencioso." In XXIX Congreso Nacional de Medicina General y de Familia y V Jornadas SEMG Andalucía. Grupo Pacífico, 2023. http://dx.doi.org/10.48158/semg23-611.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Chawathe, Sudarshan S. "Diagnostic Classification Using Hepatitis C Tests." In 2020 IEEE International IOT, Electronics and Mechatronics Conference (IEMTRONICS). IEEE, 2020. http://dx.doi.org/10.1109/iemtronics51293.2020.9216446.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Shahzadi, Mehreen, Faisal Bukhari, and Numan Shafi. "Intelligent Predictive Model for Hepatitis C." In 2023 3rd International Conference on Artificial Intelligence (ICAI). IEEE, 2023. http://dx.doi.org/10.1109/icai58407.2023.10136685.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Paschoini, MC, LN Resende, MM Mendonça, GPM Gomide, and JU Ribeiro. "P3.181 Hepatitis c: challenging modern obstetrics." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.416.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Eid, Fatma Elzahraa, Haitham Elmarakeby, Lenwood Heath, and Mahmoud ElHefnawi. "Human microRNAs targeting hepatitis C virus." In 2014 Middle East Conference on Biomedical Engineering (MECBME). IEEE, 2014. http://dx.doi.org/10.1109/mecbme.2014.6783236.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Nandian Saputra, Trimardi Aditya, Ken Indiana Arizona, Muhammad Rizky Andrian, Felix Indra Kurniadi, and Budi Juarto. "Random Forest in Detecting Hepatitis C." In 2022 9th International Conference on Information Technology, Computer, and Electrical Engineering (ICITACEE). IEEE, 2022. http://dx.doi.org/10.1109/icitacee55701.2022.9924074.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Hepatitis C"

1

Kuypers, Marshall A., Gregory Joseph Lambert, Thomas W. Moore, et al. Modeling Hepatitis C treatment policy. Office of Scientific and Technical Information (OSTI), 2013. http://dx.doi.org/10.2172/1096266.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Sjogren, Maria H., and Kent Holtzmuller. Hepatitis C Virus Infection: Mechanism of Disease Progression. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada406083.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Sjogren, Maria H. Hepatitis C. Virus Infection: Mechanism of Disease Progression. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada433067.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Sjogren, Maria H., and Brooke Huntley. Hepatitis C. Virus Infection: Mechanisms of Disease Progression. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada477987.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Adebiyi, Sadiat, Sakinah Shaw, and Tracy McClinton. Annual Hepatitis C Screening QI: A Scoping Review. University of Tennessee Health Science Center, 2022. http://dx.doi.org/10.21007/con.dnp.2022.0026.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Adebiyi, Sadiat, Sakinah Shaw, and Tracy McClinton. Annual Hepatitis C Screening QI: A Scoping Review. University of Tennessee Health Science Center, 2022. http://dx.doi.org/10.21007/con.dnp.2022.0026.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Koizumi, Yoshiki, Syo Nakajim, Hirofumi Ohash, et al. Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection. Office of Scientific and Technical Information (OSTI), 2016. http://dx.doi.org/10.2172/1242919.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Nelson, David, Michael Fried, Mark Sulkowski, et al. Comparing Oral Medicines to Treat Hepatitis C Virus -- The PRIORITIZE Study. Patient-Centered Outcomes Research Institute® (PCORI), 2022. http://dx.doi.org/10.25302/03.2022.hpc.150327891.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Flynn, James, Bethany Lemont, and Barton Willage. Subscriptions to Prescriptions: Lessons from Louisiana’s Effort to Eliminate Hepatitis C. National Bureau of Economic Research, 2025. https://doi.org/10.3386/w33617.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Hung, Hsuan-Yu, Hui-Hsiung Lai, Hui-Chuan Lin, and Chung-Yu Chen. Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C: A network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.7.0055.

Pełny tekst źródła

Streszczenie:

Review question / Objective: P: ("Hepatitis C"[Mesh] AND "Hepacivirus"[Mesh] AND "Hepatitis C, Chronic”[Mesh]) I: (direct acting antiviral OR asunaprevir OR boceprevir OR daclatasvir OR dasabuvir OR elbasvir OR glecaprevir OR grazoprevir OR ledipasvir OR ombitasvir OR paritaprevir OR pibrentasvir OR simeprevir OR sofosbuvir OR telaprevir OR velpatasvir OR voxilaprevir) C: placebo O: ( "Cholesterol, VLDL"[Mesh] OR "Cholesterol, LDL"[Mesh] OR "Cholesterol, HDL"[Mesh] OR "Dyslipidemias"[Mesh] OR "lipoprotein cholesterol ester, human" [Supplementary Concept] OR "lipoprotein cholesterol" [Supplemen

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!